In our tumor models, we were able to assess the cetuximab-mediated tumor infiltration from sMICA-inhibited NK cells toward corresponding primary HNSCC cell clusters and tumor spheroids that expressed high levels of HER1 and HER2. The gene discussed is ERBB2; the disease is head and neck squamous cell carcinoma.